Literature DB >> 26115685

Visualization of RelB expression and activation at the single-cell level during dendritic cell maturation in Relb-Venus knock-in mice.

Takao Seki1, Mami Yamamoto1, Yuu Taguchi1, Maki Miyauchi1, Nobuko Akiyama1, Noritaka Yamaguchi2, Jin Gohda3, Taishin Akiyama1, Jun-ichiro Inoue4.   

Abstract

RelB is activated by the non-canonical NF-κB pathway, which is crucial for immunity by establishing lymphoid organogenesis and B-cell and dendritic cell (DC) maturation. To elucidate the mechanism of the RelB-mediated immune cell maturation, a precise understanding of the relationship between cell maturation and RelB expression and activation at the single-cell level is required. Therefore, we generated knock-in mice expressing a fusion protein between RelB and fluorescent protein (RelB-Venus) from the Relb locus. The Relb(Venus/Venus) mice developed without any abnormalities observed in the Relb(-/-) mice, allowing us to monitor RelB-Venus expression and nuclear localization as RelB expression and activation. Relb(Venus/Venus) DC analyses revealed that DCs consist of RelB(-), RelB(low) and RelB(high) populations. The RelB(high) population, which included mature DCs with projections, displayed RelB nuclear localization, whereas RelB in the RelB(low) population was in the cytoplasm. Although both the RelB(low) and RelB(-) populations barely showed projections, MHC II and co-stimulatory molecule expression were higher in the RelB(low) than in the RelB(-) splenic conventional DCs. Taken together, our results identify the RelB(low) population as a possible novel intermediate maturation stage of cDCs and the Relb(Venus/Venus) mice as a useful tool to analyse the dynamic regulation of the non-canonical NF-κB pathway.
© The Authors 2015. Published by Oxford University Press on behalf of the Japanese Biochemical Society. All rights reserved.

Entities:  

Keywords:  NF-κB; RelB; dendritic cell; single cell; venus

Mesh:

Substances:

Year:  2015        PMID: 26115685     DOI: 10.1093/jb/mvv064

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  7 in total

1.  Deficiency of transcription factor RelB perturbs myeloid and DC development by hematopoietic-extrinsic mechanisms.

Authors:  Carlos G Briseño; Marco Gargaro; Vivek Durai; Jesse T Davidson; Derek J Theisen; David A Anderson; Deborah V Novack; Theresa L Murphy; Kenneth M Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-27       Impact factor: 11.205

Review 2.  The non-canonical NF-κB pathway in immunity and inflammation.

Authors:  Shao-Cong Sun
Journal:  Nat Rev Immunol       Date:  2017-06-05       Impact factor: 53.106

Review 3.  Chemo- and mechanosensing by dendritic cells facilitate antigen surveillance in the spleen.

Authors:  Dan Liu; Lihui Duan; Jason G Cyster
Journal:  Immunol Rev       Date:  2022-03       Impact factor: 12.988

4.  Synergistic suppression of autoimmune arthritis through concurrent treatment with tolerogenic DC and MSC.

Authors:  Rong Li; Yujuan Zhang; Xiufen Zheng; Shanshan Peng; Keng Yuan; Xusheng Zhang; Weiping Min
Journal:  Sci Rep       Date:  2017-02-23       Impact factor: 4.379

Review 5.  The Impact of Acute or Chronic Alcohol Intake on the NF-κB Signaling Pathway in Alcohol-Related Liver Disease.

Authors:  Aleksander J Nowak; Borna Relja
Journal:  Int J Mol Sci       Date:  2020-12-10       Impact factor: 5.923

Review 6.  NF-κB signaling in inflammation and cancer.

Authors:  Tao Zhang; Chao Ma; Zhiqiang Zhang; Huiyuan Zhang; Hongbo Hu
Journal:  MedComm (2020)       Date:  2021-12-16

Review 7.  Biological characteristics of transcription factor RelB in different immune cell types: implications for the treatment of multiple sclerosis.

Authors:  Meng-Ge Yang; Li Sun; Jinming Han; Chao Zheng; Hudong Liang; Jie Zhu; Tao Jin
Journal:  Mol Brain       Date:  2019-12-27       Impact factor: 4.041

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.